{"nct_id":"NCT03565991","title":"Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors","status":"TERMINATED","status_verified_date":"2023-08","start_date":"2018-06-18","start_date_type":"ACTUAL","primary_completion_date":"2022-03-28","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}